| Application no. and date | 10175369.7 (espacenet) (Federated) (European Patent Register), 20060518 | | Patent/reg. no. and date | DK/EP 2292617, 20120711 | | Publication date | 20110309 | | Priority no. and date | GB 0510390, 20050520 | | EP pub. no. and date |
EP 2292617 20110309 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | 145027 | | Inventor | Furet, Pascal,
Rue du Riegelsbourg 24
68800, Thann, FR,
Garcia-Echeverria, Carlos,
Engelgasse 126
4052, Basel, CH,
Stauffer, Frédéric,
Sonnenhofring 10
4153, Reinach, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/4188 (2006.01) , A61P 11/06 (2006.01) , A61P 29/00 (2006.01) , A61P 35/00 (2006.01) , C07D 471/04 (2006.01) | | Title | 1,3-Dihydro-imidazo[4,5-c]quinolin-2-ones som lipid kinase og/eller pi3-kinase-inhibitorer | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
